Logo SEFAC
11 April 2024
Vol. 16 N.2
Editorial
XI SEFAC Congress: strengthening primary care and claiming the clinical value of community pharmacy
Andraca L, Sánchez N.
Originals
Screening for Chronic Kidney Disease in the Community Pharmacy. CRIERFAC Study: Description of the Methodology
Salar L, Espejo J, Satué E, Pérez N, Martínez-Berganza ML.
Design of a Tool for Patient Classification Based on Pharmacotherapeutic Attitudes
Reyes D, Charola L, Horas C, Mencias AB, Arranz J, Martínez E.
Pharmaceutical Interventions in Benzodiazepine users during the COVID-19 Pandemic
Alberto-Armas D, Rubio-Armendáriz C, Hernández-García V, Santana-Ayala JR, Hardisson-de-la-Torre A, Román-Castillo Y.
Case Reports
Dose adjustment according to renal function in a polymedicated patient included in the medication reconditioning service using medication compliance aids (MCA)
Barris D, Mousavi H.
Probable pharmacological interaction between sulfonylurea and beta-blocker in a patient with DM-II. A case report
Centeno-Hoil G, Ramírez-Camacho MA, Zapata-Escalante PL, Arcos-Díaz A, Soberanis-Monsreal LA, Arana-Argáez VE.
Reviews
Diagnosis by isothermal amplification of nucleic acids. Opportunity for community pharmacies
Montero-Gómez A.

-

Manual for authors

Journal Information